When cancer patients switch their long-acting opioid analgesic medications, overall treatment costs go up, at least in part because of a need for more patient-physician interactions. A study looking at switch rates suggests that initial LAO choices are consequential with respect to both switch rates and overall costs, according to a presentation at the American Pain Society Annual Meeting in Boston, MA.
Go to Previous Page
Go to Next Page